CIK 0000718937 · Ophthalmic Goods (SIC 3851) · Nasdaq · incorporated in DE · fiscal year ends 01/02
| FY2025 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 239.4 M | |||
| Net income (USD) | 5.9 M | 14.0 M | ||
| Diluted EPS (USD/shares) | -1.62 | 0.56 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-05 | 8-K/A | 8-K/A items 5.02,7.01,9.01 | 2026-09-08 |
| 2026-09-10 | 8-K | 8-K items 5.02,7.01,9.01 | 2026-09-09 |
| 2026-08-18 | 4 | 4 | 2026-08-14 |
| 2026-08-18 | 4 | 4 | 2026-08-14 |
| 2026-08-18 | 4 | 4 | 2026-08-14 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-12 | 10-Q | 10-Q | 2026-07-03 |
| 2026-08-12 | 8-K | 8-K items 2.02,7.01,9.01 | 2026-08-12 |
| 2026-08-06 | 8-K | 8-K items 5.02,7.01,9.01 | 2026-08-05 |
| 2026-08-04 | 4 | 4 | 2026-07-31 |
| 2026-08-04 | 4 | 4 | 2026-06-25 |
| 2026-06-24 | S-8 | S-8 | |
| 2026-06-23 | 4 | OWNERSHIP DOCUMENT | 2026-06-18 |
| 2026-06-22 | 4 | 4 | 2026-06-18 |
| 2026-06-22 | 4 | 4 | 2026-06-18 |
| 2026-06-22 | 8-K | 8-K items 5.02,5.07,9.01 | 2026-06-18 |
| 2026-06-22 | 4 | 4 | 2026-06-18 |
| 2026-06-22 | 4 | 4 | 2026-06-18 |
| 2026-06-22 | 4 | 4 | 2026-06-18 |
| 2026-06-22 | 4 | 4 | 2026-06-18 |
| 2026-06-15 | 4 | 4 | 2026-06-12 |
| 2026-06-09 | 8-K | 8-K items 5.02 | 2026-06-09 |
| 2026-05-19 | 4 | 4 | 2026-05-15 |
| 2026-05-19 | 4 | 4 | 2026-05-15 |
| 2026-05-19 | 4 | 4 | 2026-05-15 |
Forms on file (last 1,000): 4 409, 8-K 236, DEFA14A 45, SC 13G/A 42, 10-Q 39, DFAN14A 35, 3 30, SCHEDULE 13D/A 20. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=STAA (0.002 USD), /gw/filings/filings?ticker=STAA&form=8-K, /gw/filings/facts?ticker=STAA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange